De-Escalation Surgery in cT3-4 Breast Cancer Patients after Neoadjuvant Therapy: Predictors of Breast Conservation and Comparison of Long-Term Oncological Outcomes with Mastectomy.
Corrado TinterriErika BarbieriAndrea SagonaAlberto BottiniGiuseppe CanaveseDamiano GentilePublished in: Cancers (2024)
BCS after NAT is a feasible and safe option for patients with cT3-4 BC, without adversely affecting long-term oncological outcomes. Identifying predictors of breast conservation can guide surgical decision-making, ensuring that patients receive optimal treatment.
Keyphrases
- rectal cancer
- end stage renal disease
- decision making
- computed tomography
- image quality
- chronic kidney disease
- ejection fraction
- dual energy
- contrast enhanced
- minimally invasive
- locally advanced
- stem cells
- squamous cell carcinoma
- randomized controlled trial
- coronary artery bypass
- type diabetes
- clinical trial
- coronary artery disease
- open label
- skeletal muscle
- radiation therapy
- study protocol
- breast reconstruction
- clinical evaluation